Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

International Stem Cell Corp

+ Add to Watchlist

0IS:GR

0.055 EUR 0.0000.00%

As of 04:22:37 ET on 03/31/2015.

Snapshot for International Stem Cell Corp (0IS)

Open: 0.055 Day's Range: 0.055 - 0.055 Volume: 0
Previous Close: 0.055 52wk Range: 0.042 - 0.143 1-Yr Rtn: -58.02%

Stock Chart for 0IS

No chart data available.
  • 0IS:GR 0.055
  • 1D
  • 1M
  • 1Y
0.055
Interactive 0IS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 0IS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.0500
Est. PEG Ratio -
Market Cap (M EUR) 13.86
Shares Outstanding (M) 252.01
30 Day Average Volume 2,862
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 0IS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 0IS

International Stem Cell Corporation develops therapeutic and research products in the biotechnology industry. The Company seeks to use human cells for use in the treatment of several diseases including diabetes, as well as in liver and retinal diseases.

Andrey SemechkinCo-Chairman/CEOJay Tibor NovakCFO/Dir:Finance/Secy
Ruslan SemechkinChief Scientific OfficerJohn Simon CrawExec VP:Bus Dev
More Company Profile & Key Executives for 0IS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil